Kerusso Capital Management LLC has disclosed its latest investment portfolio through a 13F-HR filing, revealing a total value of $306.2 million in holdings as of September 30, 2026. This report is significant as it provides insights into the firm’s investment strategies and positions in various public companies, which may influence market trends.
Among the notable investments reported are major stakes in companies like Apple Inc., Pfizer Inc., and Visa Inc. This diverse portfolio showcases Kerusso's strategic focus on established and high-performing companies across different sectors.
Background
Kerusso Capital Management LLC is a North Carolina-based investment management firm. The company is categorized under the "other" entity type and operates without a publicly traded ticker. Its recent filings include a series of 13F-HR reports, with the latest submission dated October 27, 2026, and previous filings dating back to January 2026.
What the Filing Says
The filing, identified by accession number 0001172661-26-004714, indicates that Kerusso Capital Management holds a total of 59 positions in various companies. The report highlights the firm’s investment discretion as "SOLE," meaning it has complete authority over the investments listed.
Impact
This filing may affect various stakeholders, including investors and analysts, who track the performance and strategies of investment management firms. By revealing its holdings, Kerusso Capital Management provides transparency that can influence investor sentiment and market behavior.
What's Next
The filing does not say what happens next.